Lantheus Holdings (LNTH) Net Margin (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Net Margin of 31.38% for Q1 2026, up 1181.0% year-over-year from 2.45% in Q1 2025, and up 136.02% quarter-over-quarter from 13.3% in Q4 2025.
Lantheus Holdings (LNTH) Net Margin (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Net Margin for 13 consecutive years, with 31.38% the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Margin rose 1181.0% year-over-year to 31.38%; the TTM figure through Mar 2026 stood at 18.05% (up 150.0% YoY), while the FY2025 annual figure was 15.15%, down 522.0% from the prior year.
- Net Margin climbed to 31.38% in Q1 2026 per LNTH's latest filing, from 13.3% in the prior quarter.
- Across five years, Net Margin topped out at 675.76% in Q4 2023 and bottomed at 45.29% in Q4 2022.
- Historically, Net Margin has averaged 55.33% across 5 years, with a median of 20.57% in 2022.
- Annual changes were most pronounced in 2023 — Net Margin soared 72105 bps — and 2024, when it sank 67877 bps.
- Lantheus Holdings' Net Margin stood at 45.29% in 2022, then surged by 1592 bps to 675.76% in 2023, then plunged by 100 bps to 3.01% in 2024, then jumped by 541 bps to 13.3% in 2025, then surged by 136 bps to 31.38% in 2026.
- Business Quant data shows LNTH's Net Margin at 31.38% in Q1 2026, 13.3% in Q4 2025, and 7.23% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 19.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.33% |
| Mar 31, 2026 | 31.38% |
| Dec 31, 2025 | 13.30% |
| Sep 30, 2025 | 7.23% |
| Jun 30, 2025 | 20.83% |
| Mar 31, 2025 | 19.57% |
| Dec 31, 2024 | -3.01% |
| Sep 30, 2024 | 34.61% |
| Jun 30, 2024 | 15.75% |
| Mar 31, 2024 | 35.43% |
| Dec 31, 2023 | 675.76% |
| Sep 30, 2023 | 41.24% |
| Jun 30, 2023 | 29.26% |
| Mar 31, 2023 | -0.93% |
| Dec 31, 2022 | -45.29% |
| Sep 30, 2022 | 25.59% |
| Jun 30, 2022 | 19.25% |
| Mar 31, 2022 | 20.57% |
| Dec 31, 2021 | -31.04% |
| Sep 30, 2021 | -13.14% |